skip to Main Content

From his early days in medical school, Dr. Samaha developed a fascination with the intricate details of the inner workings of the kidney where the blood is processed through its 1 million tiny filters and ensuing complex handling of, minerals, waste and other substances that are carried through its tiny “plumbing” units. This fascinating, precious, and vital organ is dear to his heart and made him pursue his specialty in Nephrology. Dr. Samaha takes this job very seriously and treats every single patient with respect, open ears, and thrives to provide patient-centered and individualized care with a service that is second to none.

In addition to his interest and work in General Nephrology since 1999, he also pursued training and practice in Interventional Nephrology in early 2002 to manage the dialysis access (known as the “lifeline”) of patients with late and end-stage kidney disease in our community. These procedures are performed in an Ambulatory Surgical Center that is state of the art with unparalleled service that is based on 3 tenets: safety, comfort, and superior outcomes. It is one of the busiest and most unique in the nation and provides all lines of services in the dialysis access field which makes it very unique not only in the Tristate area but also in the entire region. He combines this expertise with absolute devotion to compassionate care and an extensive track record of industry-leading patient satisfaction and outcomes.

Dr. Samaha is proud to be associated with the Kidney and Hypertension Center, and he is proud to serve this community in the Greater Cincinnati area that he calls home.


Primary Location(s):

Clifton (Good Sam) Office
Norwood Office

Professional Titles:

Medical Director, President, Dialysis Access Center of Cincinnati
Medical Director, Davita White Oak Home Dialysis

Board Certifications:

Internal Medicine; Nephrology; Hypertension; Diagnostic and Interventional Nephrology

Fellowship:

Vanderbilt University Medical Center

Residency:

Good Samaritan Hospital; American University of Beirut

Medical School/College:

Saint Joseph University, French Faculty of Medicine

Professional Associations:

American Society of Nephrology
National Kidney Foundation
American Society of Diagnostic and Interventional Nephrology
Renal Physician Association

Additional areas of clinical expertise, training, subspecialty certifications, or interests:

Dialysis Vascular Access (National Leadership and Expertise in this field), sub-specialty, glomerular disease, polycystic kidney disease, kidney stones, ICU nephrology, and Home dialysis


  • “Canagliflozin-linked Fanconi Syndrome: A Case Report”, Abstract/Poster presented in spring clinical meeting NKF 2016
  • “Pet Ownership and Automated Peritoneal Dialysis, Can They Coexist?”, Abstract presented in ASN annual meeting November 2012
  • “Severe and Advanced Form of Acquired Perforating Dermatosis in a Patient With End-Stage Renal Disease”. Abstract presented in ASN annual meeting November 2012
  • Book Chapter: “Arteriovenous Graft Stenosis and Thrombosis” in textbook: “Vascular Access for the General Nephrologist”; Nova Science Publisher; 2012
  • Participated in the REVISE randomized trial for the treatment of vein graft anastomosis with covered stent, Viabahn®, Gore Medical, completed enrollment in September 2011.
  • “Idiopathic Nodular Glomerulosclerosis Along With Proliferative Retinopathy and Sensorimotor Neuropathy in a Non-diabetic, Non-hypertensive Reformed Smoker”. Abstract presented in spring clinical meeting NKF 2011
  • “Complete Remission of Proteinuria with Cellcept and Cyclosporine in Non-HIV Collapsing Glomerulopathy”. Abstract presented in spring clinical meeting NKF 2011
  • “Extra-Articular Manifestations of Dialysis Related Amyloidosis: a case presentation”. Abstract presented in spring clinical meeting NKF 2010.
  • “Arterial Angioplasty to Treat Hand Ischemia in a Radial-Cephalic Fistula” (p 561-563). Seminars in Dialysis November 2009, Antoine Samaha, Loay Salman, Arif Asif
  • “Neointimal Hyperplasia in Early Arteriovenous Fistula Failure.  Prabir Roy-Chaudhury, Jianhua Zhang, Lois Arend, Antoine Samaha, Yang Wang, Mahesh Krishnamoorthy, Rino Munda. AJKD 2007
  • Participated in the Pervasis study Safety of Vascugel™ in the Creation of Arteriovenous Access for Hemodialysis Use (2007-2008)
  • Participated in the Angiotech Studies “A Randomized, Single Blind Trial to Assess the Effectiveness of Maintaining Patency and Safety of the Vascular WrapTM Paclitaxel-Eluting Mesh After Surgical Implantation with the Lifespan® ePTFE Vascular Graft in the Upper Extremity for Hemodialysis Vascular Access” and “A Long Term Safety Study of the Vascular WrapTM Paclitaxel-Eluting Mesh After Surgical Implantation with the Lifespan® ePTFE Vascular Graft in the Upper Extremity for Hemodialysis Vascular Access Use”  (2007 -2008)
  • Participated in the Mercator Study “HAPPI: Hemodialysis Access Patency Extension with Percutaneous Transluminal Infusion of Dexamethasone” (2007-2008)
  • Participated in the Paclitaxel study “A Pilot Phase II Trial of ABI-007 (A Cremophor®-Free, Protein Stabilized, Nanoparticle Paclitaxel) For the Prevention of Vascular Access Graft Failure in Patients Undergoing Hemodialysis” (2006)
  • “Early Neointimal Hyperplasia Contributes to AV Fistula Maturation Failure” Roy-Chaudhury P, Arend L, Samaha T, Zhang J, Krishnamoorthy M, Wang Y, Banerjee R, Munda R, Heffelfinger S. Aggressive. Abstract ASN 2006
  • “Line reversal in tunneled catheter and recirculation”, Abstract NKF spring meeting 2007
  • “Salvage of AVF in CKD patients”, Abstract ASN 2006
  • “What Should Nephrologists do to Maximize the Use of Arteriovenous Fistulas?”, Seminars in Dialysis, May 2006, pp. 203-205
  • “Percutaneous treatment of steal syndrome”; Abstract ASN 2005
  • “Salvaging AVF: The Cincinnati Experience on 178 patients”, Abstract ASN 2005
  • Participated in the national study on Beta Radiation for Venous Outflow: “BRAVO Trial” (09/03 – 03/04)
  • “The Impact of Vascular Access Flow Measurement by Dilutional Technique on the Thrombosis Rate”, Abstract NKF spring meeting 1999
  • Research Project: “ Accuracy of Dilutional Technique in the Detection of Hemodialysis Vascular Access Malfunction & Immediate Outcome”, 1998-1999
  • Book Chapter: “Syllabus of Proven Preventive Measures for Diabetic Nephropathy in Type 2 Diabetes Mellitus” in textbook: Diabetic Nephropathy, Antoine Samaha, Nuhad Ismail, Oxford Edition, 2000
  • “Indwelling Tunneled Femoral Catheter for Hemodialysis; A Brief Experience”, Antoine Samaha, Danny Fischer, 1997
  • “Post-Missile Brain Injury and Epilepsy”, Antoine Samaha, Nabil Okais, [French Edition], 1993
  • Invited speaker: “American Society of Diagnostic and Interventional Nephrology Annual Scientific Meeting-13”, New Orleans “Role of Central Vein Angiography when exchanging/insertion of TDC. Always or at times?” (February 2017).
  • Invited speaker: Vanderbilt University Renal Grand Round: “Hemodialysis Vascular Access Care: Continuous Challenges and Some solutions” (September 2016)
  • Invited speaker: Indiana University Renal Grand Round: “Improving Vascular Access Care Through Collaboration” (August 2015)
  • Invited speaker: RMS lifeline Physician Operating Forum: “Mega fistula and high output heart Failure” and “ Balloon assisted maturation of AVF” (February 2014)
  • Invited speaker: National Vascular Access Meeting, Cincinnati, OH: “Mega fistula and High output heart failure” and “TDC pro and con debate” (September 2013)
  • Invited speaker: “American Society of Diagnostic and Interventional Nephrology Annual Scientific Meeting-9”, Washington DC “Endovascular Management of MEGA-AVF” (February 2013).
  • Invited speaker: “National Kidney Foundation, Spring Meeting”, Washington, DC. “Complications of tunneled dialysis catheters”. (May 2012).
  • Invited speaker: “American Society of Diagnostic and Interventional Nephrology Annual Scientific Meeting-8”, New Orleans, LA. “Treatment of vein graft anastomosis: PTA or stent” (February 2012).
  • Invited speaker: “National Kidney Foundation, Spring Meeting”, Las Vegas, NV. “Complications of tunneled dialysis catheters”. (April 2011).
  • Invited speaker: “American Society of Diagnostic and Interventional Nephrology Annual Scientific Meeting-7”, Las Vegas, NV. “Treatment of vein graft anastomosis: PTA or stent” (February 2011)
  • Invited speaker and Moderator of 1 session: National Vascular Access Meeting, Cincinnati, OH: “Endovascular management of failure to mature AVF” (October 2010)
  • Invited speaker: “American Society of Diagnostic and Interventional Nephrology Annual Scientific Meeting-6”, Orlando, Florida (February 2010)
  • Invited Speaker: American Society of Nephrology annual meeting 2009, San Diego, CA: “Complications of Tunneled Dialysis Catheters” (October 2009)
  • Invited speaker: “National Kidney Foundation, Spring Meeting”, Nashville, TN (March 2009)
  • Invited Speaker: American Society of Nephrology annual meeting 2008, Philadelphia, PA: “Complications of Tunneled Dialysis Catheters” (November 2008)
  • Invited speaker: “National Kidney Foundation, Spring Meeting”, Dallas, TX (April 2008)
  • Invited Speaker: American Society of Nephrology annual meeting 2007, San Francisco, CA: “Tunneled Dialysis Catheters, Special Cases” (November 2007)
  • Invited speaker and Moderator of 2 sessions: National Vascular Access Meeting, Cincinnati, OH: “Central Vein Stenosis in the Fistula First Era” (September 2007)
  • Invited speaker: “American Society of Diagnostic and Interventional Nephrology Annual Scientific Meeting-3”, San Juan, Puerto Rico (April 2007)
  • Invited Speaker: American Society of Nephrology annual meeting 2006, San Diego, CA: “Tunneled Dialysis Catheters, Special Cases”  and “AVF: percutaneous interventions” (November 2006)
  • Invited Co-Chair (and speaker) for the “American Society of Diagnostic and Interventional Nephrology Annual Scientific Meeting”, San Antonio, TX (April 2006)
  • Invited Speaker: American Society of Nephrology annual meeting 2005, Philadelphia, PA: “Tunneled Dialysis Catheters, Special Cases” (November 2005)
  • Invited speaker, ESRD Network 9/10, Annual meeting, Indianapolis, IN: “Salvaging AVF” (May 2005). Vascular Access Learning Session
  • Genentech Editorial Board, Chicago, IL: “AVG and AVF dysfunction” (April 2005)
  • Invited speaker, ESRD Network 9/10, Columbus, OH: “Salvaging AVF” (March 2005). The Columbus meeting, Vascular Access Learning Session.
  • Invited speaker: ESRD Network 9/10, Cincinnati, OH: “Salvaging AVF” (February 2005). The Cincinnati meeting, Vascular Access Learning Session.
  • Invited speaker: International Dialysis Conference VII, New Orleans: “Innovative Approach in Salvaging AVF” (January 2005)
  • Invited speaker: American Society of Nephrology annual meeting 2004, St Louis, MO: “Tunneled Dialysis Catheters” (October 2004)
  • Invited speaker: Ohio Renal Association Spring Meeting, Columbus, OH: “Hemodialysis Vascular       Access”  (April 2004)
  • Invited speaker: Nephrology Grand Round at Vanderbilt University, Nashville, TN (April 2004); Nephrology Grand Round at University of Kentucky, Lexington, KY (November 2004): “Hemodialysis Vascular Access”
  • Invited speaker: National Vascular Access Meeting, Cincinnati, OH: “Hemodialysis Vascular Access, Local Experience” (March 2004)
  • Invited speaker: ESRD Network 9/10, Cincinnati, OH: “Access Monitoring and Surveillance” (October 2004).

Back To Top